BEIJING, Feb. 27 (Xinhua) — The Chinese National Medical Products Administration granted conditional market approval to a recombinant novel coronavirus vaccine that requires only one shot.

China conditionally approves one-shot recombinant COVID-19 vaccine
februari 27, 2021by Reacties uitgeschakeld voor China conditionally approves one-shot recombinant COVID-19 vaccine
Previous Post
Deepak Kumar settles for silver medal at Strandja Memorial
Next Post
Xinhua Asia Pacific news summary at 1600 GMT, Feb. 27